Literature DB >> 925957

Nitrous oxide analgesia: reversal by naloxone and development of tolerance.

B A Berkowitz, A D Finck, S H Ngai.   

Abstract

The objective of this study was to characterize further the nature of nitrous oxide analgesia and to establish if tolerance to nitrous oxide occurs. Methods for studying the analgesic action of a gas are described. In mice, nitrous oxide is analgesic in the phenylquinone and acetic acid abdominal constriction tests. Aspirin and very high doses of alcohol are also active in these tests; however, only nitrous oxide-induced analgesia is antagonized by narcotic antagonists. These data indicate the mechanism of action of nitrous oxide analgesia differs from that of the other two drugs. Nitrous oxide produced a dose-related analgesic response in rats (ED50, 67%) as measured by the tail-flick method. Naloxone, 5 to 30 mg/kg, also antagonized nitrous oxide analgesia in rats. Lower doses of the antagonist were not effective. Tolerance developed to the effects of nitrous oxide in both rats and mice after prolonged exposure. These data lend support to the hypothesis that nitrous oxide and opiates have a significant pharmacologic resemblance and may ultimately produce similar molecular events in the brain leading to the relief of pain.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 925957

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  31 in total

1.  Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase.

Authors:  M J DiMartino; D E Griswold; B A Berkowitz; G Poste; N Hanna
Journal:  Agents Actions       Date:  1987-02

2.  Macro- and microvascular effects of nitrous oxide in the rat.

Authors:  J L Matheny; K A Westphal; D R Richardson; G I Roth
Journal:  Anesth Prog       Date:  1991 Mar-Apr

3.  Prospective, double-blind, randomized trial of equimolar mixture of nitrous oxide/oxygen to prevent pain induced by insertion of venous access ports in cancer patients.

Authors:  Marie Cécile Douard; Mario di Palma; Patricia d'Agostino; Sylvie Chevret; Irène Kriegel; Bruno Falissard; Patrick Thierry; Brigitte George; Laurence Bussières; Jean-Louis Misset
Journal:  Support Care Cancer       Date:  2005-08-11       Impact factor: 3.603

4.  Inhibition of substance P release is the key to successful management of oral pain.

Authors:  D B Goodale
Journal:  Anesth Prog       Date:  1982 Jul-Aug

Review 5.  Naloxone: new therapeutic roles.

Authors:  B Milne; K Jhamandas
Journal:  Can Anaesth Soc J       Date:  1984-05

6.  Naloxone and its antagonism of anaesthesia and analgesia.

Authors:  M A Gillman
Journal:  Can Anaesth Soc J       Date:  1984-01

7.  Nitrous oxide as an opioid and the association between the therapeutic use of narcotics and addiction.

Authors:  M A Gillman
Journal:  Postgrad Med J       Date:  1985-07       Impact factor: 2.401

8.  The effect of naloxone and morphine on convulsions in mice following withdrawal from nitrous oxide.

Authors:  H J Manson; G Dyke; J Melling; M Gough
Journal:  Can Anaesth Soc J       Date:  1983-01

Review 9.  [Nitrous oxide. Sense or nonsense for today's anaesthesia].

Authors:  M E Schönherr; M W Hollmann; B Graf
Journal:  Anaesthesist       Date:  2004-09       Impact factor: 1.041

10.  Physical dependence on nitrous oxide in mice: resemblance to alcohol but not to opiate withdrawal.

Authors:  B Milne; F W Cervenko; K H Jhamandas
Journal:  Can Anaesth Soc J       Date:  1981-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.